A detailed history of Invesco Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 883,021 shares of CRL stock, worth $178 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
883,021
Previous 995,912 11.34%
Holding current value
$178 Million
Previous $206 Million 15.45%
% of portfolio
0.03%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$187.96 - $245.29 $21.2 Million - $27.7 Million
-112,891 Reduced 11.34%
883,021 $174 Million
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $21.3 Million - $27.8 Million
103,388 Added 11.58%
995,912 $206 Million
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $11.4 Million - $15.3 Million
-55,794 Reduced 5.88%
892,524 $242 Million
Q4 2023

Feb 12, 2024

BUY
$164.52 - $238.84 $3.36 Million - $4.88 Million
20,423 Added 2.2%
948,318 $224 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $14.8 Million - $16.5 Million
75,978 Added 8.92%
927,895 $182 Million
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $11.5 Million - $13.2 Million
62,853 Added 7.97%
851,917 $179 Million
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $21.2 Million - $28.7 Million
-110,426 Reduced 12.28%
789,064 $159 Million
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $24.9 Million - $31.6 Million
-126,369 Reduced 12.32%
899,490 $196 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $14.2 Million - $19.5 Million
77,975 Added 8.23%
1,025,859 $202 Million
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $654,236 - $969,191
-3,205 Reduced 0.34%
947,884 $203 Million
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $118 Million - $167 Million
-461,955 Reduced 32.69%
951,089 $270 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $19.1 Million - $24.3 Million
-54,267 Reduced 3.7%
1,413,044 $532 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $9.14 Million - $11.2 Million
24,526 Added 1.7%
1,467,311 $606 Million
Q2 2021

Aug 17, 2021

BUY
$294.17 - $371.65 $96.9 Million - $122 Million
329,426 Added 29.59%
1,442,785 $534 Million
Q1 2021

May 17, 2021

BUY
$249.67 - $299.48 $124 Million - $148 Million
495,568 Added 80.22%
1,113,359 $323 Million
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $43.3 Million - $49.2 Million
194,941 Added 46.1%
617,791 $154 Million
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $35.1 Million - $45.3 Million
200,048 Added 89.79%
422,850 $95.8 Million
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $3.1 Million - $4.95 Million
-26,072 Reduced 10.48%
222,802 $38.8 Million
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $2.41 Million - $4.34 Million
24,346 Added 10.84%
248,874 $31.4 Million
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $1.62 Million - $1.96 Million
-12,833 Reduced 5.41%
224,528 $34.3 Million
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $4.74 Million - $5.45 Million
-37,935 Reduced 13.78%
237,361 $31.4 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $7 Million - $8.43 Million
56,735 Added 25.96%
275,296 $39.1 Million
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $6.18 Million - $8.66 Million
-59,003 Reduced 21.26%
218,561 $31.7 Million
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $29.2 Million - $38.1 Million
277,564 New
277,564 $31.4 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.